BioCentury
ARTICLE | Clinical News

LXR regulatory update

October 27, 1997 8:00 AM UTC

LXR received U.S. Patents Nos. 5,652,210 and 5,663,070 relating to the Fas delta gene and its encoded protein, which is the naturally occurring form of the Fas receptor involved in signaling cell dea...